Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Sirolimus-associated pulmonary toxicity.

Phuong-Thu T Pham1, Phuong-Chi T Pham, Gabriel M Danovitch

  • 1David Geffen School of Medicine at UCLA, Nephrology Division, Kidney and Pancreas Transplantation, Los Angeles, CA 90095, USA. PPham@mednet.ucla.edu

Transplantation
|April 29, 2004
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Artificial intelligence and transforming cancer care.

Discover oncology·2026
Same author

Lung allograft injury improves after gastroesophageal reflux surgery by donor-derived cell-free DNA kinetics.

Frontiers in medicine·2026
Same author

Utility of donor-derived cell-free DNA testing after lung transplantation in the precision medicine era.

The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation·2026
Same author

Safety Net kidney after liver transplantation: unexpected renal recovery in a liver transplant recipient after more than 10 months on maintenance hemodialysis - a case report.

Frontiers in nephrology·2026
Same author

Outcomes and predictors of atrial fibrillation in cardiac amyloidosis.

Medicine·2026
Same author

Optimizing Primary Care Tools for Incontinence MAnagement (OPTIMA): protocol for a cluster randomized controlled trial.

Trials·2026

Sirolimus therapy can cause serious lung problems, including cough and shortness of breath. Stopping sirolimus (an immunosuppressant drug) often improves these pulmonary toxicity symptoms.

Area of Science:

  • Pulmonology
  • Pharmacology
  • Transplantation Medicine

Background:

  • Pulmonary toxicity is a recognized complication of sirolimus therapy.
  • This study details sirolimus-induced pulmonary toxicity using case reports and literature review.

Observation:

  • Dyspnea, dry cough, fatigue, and fever are common symptoms.
  • Radiographic findings include bilateral interstitial infiltrates.
  • Histologic features vary, including lymphocytic alveolitis and organizing pneumonia.

Findings:

  • 43 cases of sirolimus-induced pulmonary toxicity reported.
  • Sirolimus discontinuation or dose reduction led to rapid clinical and radiologic improvement in 15 patients.

Implications:

Related Experiment Videos

  • Clinicians must be vigilant for pulmonary complications in patients on sirolimus.
  • Early recognition and drug cessation are crucial for managing sirolimus-induced lung injury.